Depression, Unipolar Clinical Trial
Official title:
Neural Mechanisms Underlying the Antidepressant Effects of Sleep Deprivation
From 40 to 60% of patients with depression experience a rapid and significant improvement of mood with one night of sleep deprivation (SD). The neural mechanisms underlying this effect have not been elucidated. Recent advances in functional neuroimaging have provided new opportunities to investigate state changes in regional brain function, along with a better understanding of the neural networks affected by depression and SD. Here we propose to study a group of N=48 antidepressant-free male and female patients with current depression symptom and N=12 healthy controls with no history of mood disorders before and after SD to provide mechanistic insight into the neural substrates underlying the antidepressant effects of SD. We hypothesize that SD-induced concurrent functional activity and connectivity changes in multiple brain networks related to different depressive symptom dimensions including emotion regulation, attention, arousal, self-referential, and reward processing will underlie the rapid and transient antidepressant effects of SD. Using an ABA design, multimodal brain imaging along with more traditional electroencephalographic (EEG) and neurobehavioral testing data will be acquired at baseline after normal sleep, during one night of total SD, and after one night of recovery sleep using a 5-day in laboratory protocol during which subjects will be continuously monitored by trained staff.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05114824 -
Acceptability and Feasibility of an 8-week Online Mindfulness-Based Cognitive Therapy Program Among Undergraduate Students
|
N/A | |
Not yet recruiting |
NCT05958940 -
BioClock: Bright Light Therapy for Depressive Disorders
|
N/A | |
Completed |
NCT03556735 -
Pulsed Electro Magnetic Fields (PEMF) in Depression
|
N/A | |
Completed |
NCT04916548 -
Repeated Neurocognitive Measurements in Depressed Patients
|
Phase 1/Phase 2 | |
Recruiting |
NCT05767073 -
LIVES: Personalized Lifestyle Intervention for Patients With Depression
|
N/A | |
Completed |
NCT06094907 -
Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression
|
Phase 2 | |
Completed |
NCT04121091 -
Pramipexole to Target "Anhedonic Depression"
|
Phase 2 | |
Recruiting |
NCT06092411 -
Effects of CBT and BLT in Youth With Unipolar Depression and Evening Chronotype
|
N/A | |
Enrolling by invitation |
NCT03847688 -
Machine Learning to Predict Clinical Response to TMS
|
||
Completed |
NCT02945735 -
Gaze Contingent Feedback in Major Depressive Disorder (MDD)
|
N/A | |
Recruiting |
NCT06139159 -
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
|
N/A | |
Recruiting |
NCT05011864 -
Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression
|
N/A | |
Terminated |
NCT03537547 -
Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder
|
Phase 4 | |
Completed |
NCT03515733 -
PF-04995274 and Emotional Processing in Treatment Resistant Depression
|
Phase 1 | |
Not yet recruiting |
NCT05991232 -
Repeated Neurocognitive Measurements in Depressed Patients
|
Phase 1/Phase 2 | |
Completed |
NCT03516604 -
PF-04995274 and Emotional Processing in Un-medicated Depression
|
Phase 1 | |
Completed |
NCT03538275 -
Chronobiology and Depression: Circadian Analytics as a Biomarker for Depressive Subtypes
|
||
Active, not recruiting |
NCT03096886 -
Novel Neural Circuit Biomarkers of Major Depression Response to CCBT
|
N/A | |
Not yet recruiting |
NCT06462196 -
Natural History of Depression, Bipolar Disorder and Suicide Risk
|
||
Completed |
NCT01874951 -
Low-Dose Naltrexone for Depression Relapse and Recurrence
|
Phase 2 |